LEMAITRE VASCULAR, INC. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
LEMAITRE VASCULAR, INC. (LMAT) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $33.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-02-26
- LEMAITRE VASCULAR, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for the quarter ending 2024-12-31 was $30.00K.
- LEMAITRE VASCULAR, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for the quarter ending 2024-09-30 was -$36.00K, a 427.27% decline year-over-year.
- LEMAITRE VASCULAR, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for the quarter ending 2024-06-30 was $17.00K, a 39.29% decline year-over-year.
- LEMAITRE VASCULAR, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for the quarter ending 2024-03-31 was $22.00K, a 450.00% increase year-over-year.
- LEMAITRE VASCULAR, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $33.00K, a 32.00% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $25.00K, a 56.14% decline from fiscal 2022.
- LEMAITRE VASCULAR, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $57.00K, a 9.62% increase from fiscal 2021.
- LEMAITRE VASCULAR, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2021 was $52.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 3 month | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 6 month | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 9 month | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|---|---|---|
| 2024-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$6.00K derived: sum of 2 quarters · filed 2026-02-26 | $11.00K derived: sum of 3 quarters · filed 2026-02-26 | $33.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$19.00K derived: sum of 2 quarters · filed 2024-11-08 | $3.00K 10-Q · filed 2024-11-08 | -$15.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $39.00K 10-Q · filed 2024-08-08 | $21.00K derived: sum of 3 quarters · filed 2026-02-26 | $32.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $22.00K 10-Q · filed 2024-05-10 | $4.00K derived: sum of 2 quarters · filed 2026-02-26 | $15.00K derived: sum of 3 quarters · filed 2026-02-26 | $43.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$7.00K derived: sum of 2 quarters · filed 2026-02-26 | $21.00K derived: sum of 3 quarters · filed 2026-02-26 | $25.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $39.00K derived: sum of 2 quarters · filed 2023-11-07 | $43.00K 10-Q · filed 2023-11-07 | $5.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $32.00K 10-Q · filed 2023-08-08 | -$6.00K derived: sum of 3 quarters · filed 2025-02-28 | $23.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $4.00K 10-Q · filed 2023-05-09 | -$34.00K derived: sum of 2 quarters · filed 2025-02-28 | -$5.00K derived: sum of 3 quarters · filed 2025-02-28 | $42.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$9.00K derived: sum of 2 quarters · filed 2025-02-28 | $38.00K derived: sum of 3 quarters · filed 2025-02-28 | $57.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $76.00K derived: sum of 2 quarters · filed 2022-11-08 | $95.00K 10-Q · filed 2022-11-08 | $114.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $66.00K 10-Q · filed 2022-08-05 | $85.00K derived: sum of 3 quarters · filed 2024-02-29 | $92.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $19.00K 10-Q · filed 2022-05-10 | $38.00K derived: sum of 2 quarters · filed 2024-02-29 | $45.00K derived: sum of 3 quarters · filed 2024-02-29 | |
| 2021-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $26.00K derived: sum of 2 quarters · filed 2024-02-29 | $52.00K 10-K · filed 2024-02-29 | |
| 2021-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $33.00K 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | $26.00K 10-Q · filed 2021-08-05 | |||
| 2020-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $4.00K 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | $9.00K 10-Q · filed 2020-05-08 | |||
| 2010-12-31 | $22.00K 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |